Comparative Confusion: What Does FDA Intend For Opioid Comparative Efficacy Data?

Legally, FDA can't require comparative effectiveness data for approval, but draft guidance notes that the agency really wants it; for sponsors, that leaves more questions than answers, mainly: What will FDA do with an opioid application that doesn't contain such data.

Drugs question mark
How will FDA react if an opioid application does not include comparative efficacy and safety data? • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards